within Pharmacolibrary.Drugs.ATC.N;

model N06AF06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06AF06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Iproclozide is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) that was used as an antidepressant. It is now withdrawn from clinical use in most countries due to risk of hepatotoxicity and safer alternatives.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult, as no published human PK studies or data are available.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06AF06;
